Literature DB >> 9215020

Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation.

G A Egli1, A Zollinger, B Seifert, D Popovic, T Pasch, D R Spahn.   

Abstract

We have compared the effects of progressive (30% and 60%) in vitro haemodilution with hydroxyethyl starch (HES), gelatin (GEL) and albumin (ALB) with haemodilution using 0.9% saline in 96 patients by thrombelastography. Haemodilution with HES, GEL and ALB significantly (P < 0.05) compromised coagulation time (k), angle alpha and maximal amplitude (MA), with HES having the most negative effect at 30% and 60% haemodilution (P < 0.05). Haemodilution with saline significantly affected all variables of blood coagulation and clot lysis measured by thrombelastography, resulting in an increased coagulability at 30% haemodilution. To specifically assess the intrinsic effect of plasma expander molecules on blood coagulation and clot lysis, we analysed the difference between saline diluted blood (same degree of haemodilution) and plasma expander diluted blood. Prolongation of reaction time (r) was found for HES at 30% and 60% haemodilution and for ALB at 60% haemodilution and an increase in clot lysis by HES, GEL and ALB became evident. We conclude that HES, GEL and ALB compromised blood coagulation, while the maximum effect was found with HES.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215020     DOI: 10.1093/bja/78.6.684

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  16 in total

1.  The effects of commonly used resuscitation fluids on whole blood coagulation.

Authors:  T J Coats; E Brazil; M Heron
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

2.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

Review 3.  Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review.

Authors:  Christiane S Hartog; Dorit Reuter; Wolfgang Loesche; Michael Hofmann; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2011-10-12       Impact factor: 17.440

4.  Preoperative acute hypervolemic hemodilution with hydroxyethylstarch in a Jehovah's Witness: effects on hemodynamics and coagulation systems.

Authors:  Michiko Sugita; Kazuo Ushijima; Keisuke Ichinose; Hidenori Terasaki
Journal:  J Anesth       Date:  1998-09       Impact factor: 2.078

5.  Ethyl Hydroxyethyl Cellulose-A Biocompatible Polymer Carrier in Blood.

Authors:  Anja Eckelt; Franziska Wichmann; Franziska Bayer; John Eckelt; Jonathan Groß; Till Opatz; Kerstin Jurk; Christoph Reinhardt; Klytaimnistra Kiouptsi
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

6.  The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.

Authors:  Christoph Johannes Schlimp; Janne Cadamuro; Cristina Solomon; Heinz Redl; Herbert Schöchl
Journal:  Blood Transfus       Date:  2012-12-13       Impact factor: 3.443

7.  Influence of colloid infusion on coagulation during off-pump coronary artery bypass grafting.

Authors:  K Muralidhar; Rajnish Garg; Sk Mohanty; Sanjay Banakal
Journal:  Indian J Anaesth       Date:  2010-03

8.  Does calcium cause the different effects of Gelofusine and Haemaccel on coagulation?

Authors:  T J Coats; M Heron
Journal:  Emerg Med J       Date:  2006-03       Impact factor: 2.740

Review 9.  Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions.

Authors:  D R Spahn
Journal:  Crit Care       Date:  1999-09-24       Impact factor: 9.097

10.  Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.

Authors:  Dag Winstedt; Nahreen Tynngård; Knut Olanders; Ulf Schött
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-03-22       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.